|
Market Closed -
OTC Markets
22:46:02 30/10/2025 +04
|
5-day change | 1st Jan Change | ||
| 3.550 USD | -11.25% |
|
-11.03% | +10.94% |
Company Valuation: RetinalGenix Technologies Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 155.4 | 54.35 | 94.87 | 59.54 |
| Change | - | -65.04% | 74.56% | -37.25% |
| Enterprise Value (EV) 1 | 155.6 | 54.86 | 95.39 | 60.07 |
| Change | - | -64.75% | 73.89% | -37.03% |
| P/E | -35.8x | -25.6x | -21.8x | -24.5x |
| PBR | -145x | -38.8x | -66.5x | -26.1x |
| PEG | -0x | 0.5x | -0.2x | 0.5x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | - | - | - |
| EV / EBIT | -82.9x | -26.3x | -22.1x | -24.8x |
| EV / FCF | -387x | - | - | 171x |
| FCF Yield | -0.26% | - | - | 0.58% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.2511 | -0.1205 | -0.2408 | -0.1308 |
| Distribution rate | - | - | - | - |
| Net sales | - | - | - | - |
| EBITDA | -1.876 | -2.087 | -4.317 | -2.425 |
| EBIT 1 | -1.876 | -2.087 | -4.317 | -2.425 |
| Net income 1 | -3.914 | -2.091 | -4.321 | -2.429 |
| Net Debt 1 | 0.1581 | 0.5065 | 0.5183 | 0.53 |
| Reference price 2 | 9.000 | 3.090 | 5.250 | 3.200 |
| Nbr of stocks (in thousands) | 17,272 | 17,589 | 18,071 | 18,605 |
| Announcement Date | 31/03/23 | 01/04/24 | 31/03/25 | 15/04/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 75.19M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 39.06B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RTGN Stock
- Valuation RetinalGenix Technologies Inc.
Select your edition
All financial news and data tailored to specific country editions
